Go Back

Are barriers to eCOA adoption true hurdles?

Over recent years, as an industry, we seem to have created a paradox: we increase investment in technological developments, but the adoption rate remains low. In 2019, as few as 31% of sponsors were familiar with and used mobile health technologies and virtual approaches in clinical trials.1

Electronic Clinical Outcome Assessment (eCOA) solutions are increasingly preferred to paper questionnaires for endpoint data collection in clinical and epidemiological studies. However, insuperable barriers hinder the widespread use of eCOA.

What are these barriers and are they wrongly perceived as being insurmountable? Mrs Estelle Haenel, Medical Director at Kayentis, talks through those misconceptions.

Discover the full videos and transcripts:


Last update : 12 December 2019


  • 26 October
    OCT Europe 2020 - October 26-27 - Paris, France - Booth #83 - Schedule a meeting with Kayentis
  • 02 November
    Clinical Trials Europe - Nov 2-4 - Amsterdam, The Netherlands - Booth #88 - Schedule a meeting with Kayentis     Clinical Trials Europe
  • 08 November
    DIA Japan - Nov 8-10 - Tokyo Big Sight, Ariake - Booth #17 -  Schedule a meeting with Kayentis
  • Follow us

    Download our brochure